Copyright Reports & Markets. All rights reserved.

Global Chronic Venous Insufficiency Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Chronic Venous Insufficiency by Type
    • 1.3.1 Overview: Global Chronic Venous Insufficiency Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Chronic Venous Insufficiency Consumption Value Market Share by Type in 2024
    • 1.3.3 Medical Equipment and Consumables
    • 1.3.4 Drugs
  • 1.4 Global Chronic Venous Insufficiency Market by Application
    • 1.4.1 Overview: Global Chronic Venous Insufficiency Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Chronic Venous Insufficiency Market Size & Forecast
  • 1.6 Global Chronic Venous Insufficiency Market Size and Forecast by Region
    • 1.6.1 Global Chronic Venous Insufficiency Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Chronic Venous Insufficiency Market Size by Region, (2020-2031)
    • 1.6.3 North America Chronic Venous Insufficiency Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Chronic Venous Insufficiency Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Chronic Venous Insufficiency Market Size and Prospect (2020-2031)
    • 1.6.6 South America Chronic Venous Insufficiency Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Chronic Venous Insufficiency Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Shanghai Lanmai Medical Technology
    • 2.1.1 Shanghai Lanmai Medical Technology Details
    • 2.1.2 Shanghai Lanmai Medical Technology Major Business
    • 2.1.3 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Product and Solutions
    • 2.1.4 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Shanghai Lanmai Medical Technology Recent Developments and Future Plans
  • 2.2 Hangzhou Weiqiang Medical Technology
    • 2.2.1 Hangzhou Weiqiang Medical Technology Details
    • 2.2.2 Hangzhou Weiqiang Medical Technology Major Business
    • 2.2.3 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Product and Solutions
    • 2.2.4 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Hangzhou Weiqiang Medical Technology Recent Developments and Future Plans
  • 2.3 Suzhou Yinluo Medical Devices
    • 2.3.1 Suzhou Yinluo Medical Devices Details
    • 2.3.2 Suzhou Yinluo Medical Devices Major Business
    • 2.3.3 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Product and Solutions
    • 2.3.4 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Suzhou Yinluo Medical Devices Recent Developments and Future Plans
  • 2.4 Zylox-Tonbridge Medical Technology
    • 2.4.1 Zylox-Tonbridge Medical Technology Details
    • 2.4.2 Zylox-Tonbridge Medical Technology Major Business
    • 2.4.3 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Product and Solutions
    • 2.4.4 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Zylox-Tonbridge Medical Technology Recent Developments and Future Plans
  • 2.5 Shanghai Ensheng Medical Technology
    • 2.5.1 Shanghai Ensheng Medical Technology Details
    • 2.5.2 Shanghai Ensheng Medical Technology Major Business
    • 2.5.3 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Product and Solutions
    • 2.5.4 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Shanghai Ensheng Medical Technology Recent Developments and Future Plans
  • 2.6 Suzhou Tianhong Shengjie Medical Devices
    • 2.6.1 Suzhou Tianhong Shengjie Medical Devices Details
    • 2.6.2 Suzhou Tianhong Shengjie Medical Devices Major Business
    • 2.6.3 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Product and Solutions
    • 2.6.4 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Suzhou Tianhong Shengjie Medical Devices Recent Developments and Future Plans
  • 2.7 BD(Angiomed)
    • 2.7.1 BD(Angiomed) Details
    • 2.7.2 BD(Angiomed) Major Business
    • 2.7.3 BD(Angiomed) Chronic Venous Insufficiency Product and Solutions
    • 2.7.4 BD(Angiomed) Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 BD(Angiomed) Recent Developments and Future Plans
  • 2.8 Boston Scientific
    • 2.8.1 Boston Scientific Details
    • 2.8.2 Boston Scientific Major Business
    • 2.8.3 Boston Scientific Chronic Venous Insufficiency Product and Solutions
    • 2.8.4 Boston Scientific Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Boston Scientific Recent Developments and Future Plans
  • 2.9 Cook Ireland
    • 2.9.1 Cook Ireland Details
    • 2.9.2 Cook Ireland Major Business
    • 2.9.3 Cook Ireland Chronic Venous Insufficiency Product and Solutions
    • 2.9.4 Cook Ireland Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Cook Ireland Recent Developments and Future Plans
  • 2.10 Medtronic
    • 2.10.1 Medtronic Details
    • 2.10.2 Medtronic Major Business
    • 2.10.3 Medtronic Chronic Venous Insufficiency Product and Solutions
    • 2.10.4 Medtronic Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Medtronic Recent Developments and Future Plans
  • 2.11 optimed Medizinische Instrumente
    • 2.11.1 optimed Medizinische Instrumente Details
    • 2.11.2 optimed Medizinische Instrumente Major Business
    • 2.11.3 optimed Medizinische Instrumente Chronic Venous Insufficiency Product and Solutions
    • 2.11.4 optimed Medizinische Instrumente Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 optimed Medizinische Instrumente Recent Developments and Future Plans
  • 2.12 Philips
    • 2.12.1 Philips Details
    • 2.12.2 Philips Major Business
    • 2.12.3 Philips Chronic Venous Insufficiency Product and Solutions
    • 2.12.4 Philips Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Philips Recent Developments and Future Plans
  • 2.13 3M
    • 2.13.1 3M Details
    • 2.13.2 3M Major Business
    • 2.13.3 3M Chronic Venous Insufficiency Product and Solutions
    • 2.13.4 3M Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 3M Recent Developments and Future Plans
  • 2.14 Teva
    • 2.14.1 Teva Details
    • 2.14.2 Teva Major Business
    • 2.14.3 Teva Chronic Venous Insufficiency Product and Solutions
    • 2.14.4 Teva Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Teva Recent Developments and Future Plans
  • 2.15 Mylan
    • 2.15.1 Mylan Details
    • 2.15.2 Mylan Major Business
    • 2.15.3 Mylan Chronic Venous Insufficiency Product and Solutions
    • 2.15.4 Mylan Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Mylan Recent Developments and Future Plans
  • 2.16 Pfizer
    • 2.16.1 Pfizer Details
    • 2.16.2 Pfizer Major Business
    • 2.16.3 Pfizer Chronic Venous Insufficiency Product and Solutions
    • 2.16.4 Pfizer Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Pfizer Recent Developments and Future Plans
  • 2.17 AbbVie
    • 2.17.1 AbbVie Details
    • 2.17.2 AbbVie Major Business
    • 2.17.3 AbbVie Chronic Venous Insufficiency Product and Solutions
    • 2.17.4 AbbVie Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 AbbVie Recent Developments and Future Plans
  • 2.18 Abbott
    • 2.18.1 Abbott Details
    • 2.18.2 Abbott Major Business
    • 2.18.3 Abbott Chronic Venous Insufficiency Product and Solutions
    • 2.18.4 Abbott Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Abbott Recent Developments and Future Plans
  • 2.19 Allergan
    • 2.19.1 Allergan Details
    • 2.19.2 Allergan Major Business
    • 2.19.3 Allergan Chronic Venous Insufficiency Product and Solutions
    • 2.19.4 Allergan Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Allergan Recent Developments and Future Plans
  • 2.20 Sun Pharma
    • 2.20.1 Sun Pharma Details
    • 2.20.2 Sun Pharma Major Business
    • 2.20.3 Sun Pharma Chronic Venous Insufficiency Product and Solutions
    • 2.20.4 Sun Pharma Chronic Venous Insufficiency Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Sun Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Chronic Venous Insufficiency Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Chronic Venous Insufficiency by Company Revenue
    • 3.2.2 Top 3 Chronic Venous Insufficiency Players Market Share in 2024
    • 3.2.3 Top 6 Chronic Venous Insufficiency Players Market Share in 2024
  • 3.3 Chronic Venous Insufficiency Market: Overall Company Footprint Analysis
    • 3.3.1 Chronic Venous Insufficiency Market: Region Footprint
    • 3.3.2 Chronic Venous Insufficiency Market: Company Product Type Footprint
    • 3.3.3 Chronic Venous Insufficiency Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Chronic Venous Insufficiency Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Chronic Venous Insufficiency Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Chronic Venous Insufficiency Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Chronic Venous Insufficiency Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Chronic Venous Insufficiency Consumption Value by Type (2020-2031)
  • 6.2 North America Chronic Venous Insufficiency Market Size by Application (2020-2031)
  • 6.3 North America Chronic Venous Insufficiency Market Size by Country
    • 6.3.1 North America Chronic Venous Insufficiency Consumption Value by Country (2020-2031)
    • 6.3.2 United States Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Chronic Venous Insufficiency Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Chronic Venous Insufficiency Consumption Value by Type (2020-2031)
  • 7.2 Europe Chronic Venous Insufficiency Consumption Value by Application (2020-2031)
  • 7.3 Europe Chronic Venous Insufficiency Market Size by Country
    • 7.3.1 Europe Chronic Venous Insufficiency Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 7.3.3 France Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Chronic Venous Insufficiency Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Chronic Venous Insufficiency Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Chronic Venous Insufficiency Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Chronic Venous Insufficiency Market Size by Region
    • 8.3.1 Asia-Pacific Chronic Venous Insufficiency Consumption Value by Region (2020-2031)
    • 8.3.2 China Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 8.3.5 India Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Chronic Venous Insufficiency Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Chronic Venous Insufficiency Consumption Value by Type (2020-2031)
  • 9.2 South America Chronic Venous Insufficiency Consumption Value by Application (2020-2031)
  • 9.3 South America Chronic Venous Insufficiency Market Size by Country
    • 9.3.1 South America Chronic Venous Insufficiency Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Chronic Venous Insufficiency Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Chronic Venous Insufficiency Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Chronic Venous Insufficiency Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Chronic Venous Insufficiency Market Size by Country
    • 10.3.1 Middle East & Africa Chronic Venous Insufficiency Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Chronic Venous Insufficiency Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Chronic Venous Insufficiency Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Chronic Venous Insufficiency Market Drivers
  • 11.2 Chronic Venous Insufficiency Market Restraints
  • 11.3 Chronic Venous Insufficiency Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Chronic Venous Insufficiency Industry Chain
  • 12.2 Chronic Venous Insufficiency Upstream Analysis
  • 12.3 Chronic Venous Insufficiency Midstream Analysis
  • 12.4 Chronic Venous Insufficiency Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our latest research, the global Chronic Venous Insufficiency market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.
    Chronic venous insufficiency (CVI) is a common progressive disease that affects the superficial and deep venous systems of the lower extremities. CVI is characterized by valvular insufficiency, reflux, venous obstruction, or a combination, leading to distal venous hypertension. Clinical manifestations of CVI include edema, pain, skin changes, ulcers, and dilated cutaneous veins of the lower extremities.

    This report is a detailed and comprehensive analysis for global Chronic Venous Insufficiency market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Chronic Venous Insufficiency market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Chronic Venous Insufficiency market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Chronic Venous Insufficiency market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Chronic Venous Insufficiency market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Chronic Venous Insufficiency
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Chronic Venous Insufficiency market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Lanmai Medical Technology, Hangzhou Weiqiang Medical Technology, Suzhou Yinluo Medical Devices, Zylox-Tonbridge Medical Technology, Shanghai Ensheng Medical Technology, Suzhou Tianhong Shengjie Medical Devices, BD(Angiomed), Boston Scientific, Cook Ireland, Medtronic, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Chronic Venous Insufficiency market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Medical Equipment and Consumables
    Drugs
    Market segment by Application
    Hospital
    Clinic
    Other
    Market segment by players, this report covers
    Shanghai Lanmai Medical Technology
    Hangzhou Weiqiang Medical Technology
    Suzhou Yinluo Medical Devices
    Zylox-Tonbridge Medical Technology
    Shanghai Ensheng Medical Technology
    Suzhou Tianhong Shengjie Medical Devices
    BD(Angiomed)
    Boston Scientific
    Cook Ireland
    Medtronic
    optimed Medizinische Instrumente
    Philips
    3M
    Teva
    Mylan
    Pfizer
    AbbVie
    Abbott
    Allergan
    Sun Pharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Chronic Venous Insufficiency product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Chronic Venous Insufficiency, with revenue, gross margin, and global market share of Chronic Venous Insufficiency from 2020 to 2025.
    Chapter 3, the Chronic Venous Insufficiency competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Chronic Venous Insufficiency market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Venous Insufficiency.
    Chapter 13, to describe Chronic Venous Insufficiency research findings and conclusion.

    Buy now